Logo

Accelrys Shares Recover from Early Plunge on Non-Compliance News

Feb 10, 2006

NEW YORK, Feb.10 (GenomeWeb News) - Shares of Accelrys plunged 20 percent today after the company said it expected a letter of non-compliance from Nasdaq.

 

As GenomeWeb reported, Accelrys will delay its third quarter earnings due to ongoing discussions with the SEC regarding the company's financial restatements. https://www.genomeweb.com/articles/view-article.asp?Article=200621092114

 

Accelrys shares were trading off $0.27, or 4.29%, at $6.03 in mid-afternoon trade.

 

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.